Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | Director | September 15, 2021 | September 17, 2021 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 15, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,583 |
Ending reported balance
After 2021-09-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-09-15 · Exercise / conversion · Acquired 4,000 · Balance 21,583 Row 2 · 2021-09-15 · Sale · Disposed 4,000 · Balance 17,583 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.54 · Expires 2022-05-15 | Direct | 11,806 |
Reported balance
After 2021-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-15 · Exercise / conversion · Disposed 4,000 · Balance 11,806 F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015.
TACTILE SYSTEMS TECHNOLOGY INC
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,841 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,521 · Balance 62,841 F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTRICON CORP
Report date May 24, 2022 · Filed May 25, 2022
Section 16 reporting ended · disclosed 2022-05-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-24 transaction · row 1
1 source rowRow 1 · 2022-05-24 · Disposition to issuer · Disposed 11,154 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2026 Filed May 8, 2026 21:31 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001596078-26-000002 · form4-05082026_090525.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,841 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:27 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 16,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015800 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,320 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:22 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 10,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-016021 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,242 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:26 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 7,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-013626 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,773 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 24, 2022 Filed May 25, 2022 14:41 UTC | INTRICON CORP IIN · Entity 126953 | Disposition to issuerCommon Stock | 11,154 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897101-22-000560 · ownership.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:24 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011955 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,036 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:53 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-056662 · doc4.xml · derivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,806 Underlying: Common Stock · 4,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:53 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,000 | $49.00 | $196,000.00 |
DisclosureSEC source: 0001209191-21-056662 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:53 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,000 | $38.54 | $154,160.00 |
DisclosureSEC source: 0001209191-21-056662 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:46 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,594 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-052418 · doc4.xml · derivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,594 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. F6 · balance_after: The reported shares were granted as a single stock option and initially reported as a single line item on the Form 4 dated 05/15/2015 reporting the option grant. In subsequent Form 4s the option was split into a NSO portion and an ISO portion, each of which has been reported as a separate line item. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:46 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-052418 · doc4.xml · derivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,806 Underlying: Common Stock · 4,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. F6 · balance_after: The reported shares were granted as a single stock option and initially reported as a single line item on the Form 4 dated 05/15/2015 reporting the option grant. In subsequent Form 4s the option was split into a NSO portion and an ISO portion, each of which has been reported as a separate line item. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:46 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,604 | $63.19 | $164,541.55 |
DisclosureSEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F4 · price: Represents the weighted average share price of an aggregate total of 2,604 shares sold in the price range of $63.00 to $63.41 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:46 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,990 | $62.70 | $187,476.89 |
DisclosureSEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,187 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F3 · price: Represents the weighted average share price of an aggregate total of 2,990 shares sold in the price range of $62.00 to $62.99 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:46 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,000 | $61.36 | $61,364.40 |
DisclosureSEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,177 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F2 · price: Represents the weighted average share price of an aggregate total of 1,000 shares sold in the price range of $60.93 to $61.91 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:46 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,594 | $38.54 | $99,972.76 |
DisclosureSEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 23:46 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,000 | $38.54 | $154,160.00 |
DisclosureSEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:26 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-047290 · doc4.xml · derivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,806 Underlying: Common Stock · 4,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:26 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 178 | $66.62 | $11,858.36 |
DisclosureSEC source: 0001209191-21-047290 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F3 · price: Represents the share price of an aggregate total of 178 shares sold at a price of $66.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:26 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,822 | $65.81 | $448,963.32 |
DisclosureSEC source: 0001209191-21-047290 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,761 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F2 · price: Represents the weighted average share price of an aggregate total of 6,822 shares sold in the price range of $65.258 to $66.23 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:26 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,000 | $38.54 | $154,160.00 |
DisclosureSEC source: 0001209191-21-047290 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-21-041522 · doc4.xml · derivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,806 Underlying: Common Stock · 4,000 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F4 · balance_after: The previously filed Form 4 on January 16, 2019 listed an incorrect number. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,087 | $63.73 | $196,749.64 |
DisclosureSEC source: 0001209191-21-041522 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F3 · price: Represents the weighted average share price of an aggregate total of 3,087 shares sold in the price range of $63.11 to $64.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,000 | $63.87 | $255,462.40 |
DisclosureSEC source: 0001209191-21-041522 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,670 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. F2 · price: Represents the weighted average share price of an aggregate total of 4,000 shares sold in the price range of $63.28 to $64.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:09 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,000 | $38.54 | $154,160.00 |
DisclosureSEC source: 0001209191-21-041522 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:04 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 2,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012779 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,933 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 10, 2021 Filed May 12, 2021 23:45 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032220 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,670 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 04, 2021 Filed May 5, 2021 16:26 UTC | INTRICON CORP IIN · Entity 126953 | GrantCommon Stock | 3,302 | $0.00 | $0.00 |
DisclosureSEC source: 0000897101-21-000362 · ownership.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,154 Read SEC document |
| March 23, 2021 Filed Mar 31, 2021 23:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,087 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-21-023873 · doc4.xml · derivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,087 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| March 23, 2021 Filed Mar 31, 2021 23:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 6,087 | $16.62 | $101,165.94 |
DisclosureSEC source: 0001209191-21-023873 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:56 UTC | INTRICON CORP IIN · Entity 126953 | GrantCommon Stock | 256 | $0.00 | $0.00 |
DisclosureSEC source: 0000897101-21-000202 · ownership.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,852 Read SEC document |
| May 11, 2020 Filed May 12, 2020 22:31 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 4,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-028627 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,829 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the Reporting Person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 2,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-009605 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,443 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 16:32 UTC | INTRICON CORP IIN · Entity 126953 | GrantCommon Stock | 4,987 | $0.00 | $0.00 |
DisclosureSEC source: 0000897101-20-000301 · ownership.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,596 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 4,987 restricted stock units under the Issuer's 2015 Equity Incentive Plan. Read SEC document |
| May 09, 2019 Filed May 10, 2019 20:49 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-028982 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,271 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:56 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-009682 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,771 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 09, 2019 Filed May 22, 2019 01:00 UTC Amendment | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031883 · doc4a.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,289 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| May 01, 2019 Filed May 3, 2019 16:33 UTC | INTRICON CORP IIN · Entity 126953 | GrantCommon Stock | 2,609 | $0.00 | $0.00 |
DisclosureSEC source: 0000897101-19-000430 · ownership.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,609 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,609 restricted stock units under the Issuer's 2015 Equity Incentive Plan. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · derivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,800 Underlying: Common Stock · 2,500 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · derivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,400 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · derivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,087 Underlying: Common Stock · 3,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 282 | $141.66 | $39,948.12 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/2018 F4 · price: Represents the weighted average share price of an aggregate total of 282 shares sold in the price range of $141.58 to $141.71 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 574 | $139.11 | $79,849.14 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,079 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/2018 Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 995 | $137.95 | $137,260.25 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,653 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/2018 F3 · price: Represents the weighted average share price of an aggregate total of 995 shares sold in the price range of $137.65 to $138.26 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,649 | $136.24 | $905,859.76 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,648 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/2018 F2 · price: Represents the weighted average share price of an aggregate total of 6,649 shares sold in the price range of $135.97 to $136.95 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 22:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,500 | $16.62 | $58,170.00 |
DisclosureSEC source: 0001209191-19-003961 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · derivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,300 Underlying: Common Stock · 2,500 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · derivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,900 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · derivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,587 Underlying: Common Stock · 3,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.